Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13K Sell
25,111
-29,827
-54% -$17.8K ﹤0.01% 4092
2026
Q1
$34.6K Sell
54,938
-92,232
-63% -$69.4K ﹤0.01% 4016
2025
Q4
$129K Buy
+147,170
New +$157K ﹤0.01% 3980
2023
Q3
Sell
-127,717
Closed -$1.2M 3901
2023
Q2
$1.2M Buy
127,717
+6,159
+5% +$54.1K ﹤0.01% 3094
2023
Q1
$1.05M Buy
121,558
+25
+0% +$220 ﹤0.01% 3127
2022
Q4
$859K Buy
121,533
+101,277
+500% +$850K ﹤0.01% 3203
2022
Q3
$201K Buy
+20,256
New +$183K ﹤0.01% 3706

Other funds holding DCGO

Ameriprise's DCGO Position: Q2 2026 in Review

Ameriprise reduced its DocGo (DCGO) stake by 54% in Q2 2026, selling an estimated $17.8K and leaving 25,111 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #4092.

Ameriprise first reported a position in DCGO in Q3 2022 and has held it in 7 quarters since. The position peaked at $1.2M in Q2 2023. 119 funds tracked by Wall St. Rank hold DCGO as of Q2 2026.

  • Ameriprise held 25,111 shares of DocGo worth $13K as of Q2 2026.
  • Ameriprise sold 29,827 DocGo shares in Q2 2026, an estimated $17.8K.
  • DocGo made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #4092 holding.
  • Ameriprise first reported a position in DocGo in Q3 2022 and has held it in 7 quarters since.
  • Ameriprise's DocGo position peaked at $1.2M in Q2 2023.
  • 119 funds tracked by Wall St. Rank held DocGo as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.